BRET-based ligand binding on BMG readers
- Company/University: Harry Perkins Institute of Medical Research at the University of Western Australia and Dimerix
- Interviewee: Kevin Pfleger
- Products used: PHERAstar and CLARIOstar
- Method: ligand binding of GPCRs, protein-protein interaction, luminescence, BRET, NanoBRET, competitive binding
Kevin Pfleger from the Harry Perkins Institute of Medical Research at the University of Western Australia talks about his experience with NanoBRET assays on the the CLARIOstar® and PHERAstar®FSX plate readers.